EP3313528
SKAMMTAÁÆTLANIR ÓNÆMISMEÐFERÐAR SEM FELA Í SÉR PÓMALÍDÓMÍÐ OG MÓTEFNI GEGN CS1 TIL AÐ MEÐHÖNDLA KRABBAMEIN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.6.2016EP published:
4.8.2021EP application number:
16738609.3
EP translation filed:
22.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
27.6.2036Expiry date:
27.6.2026Next due date:
30.6.2026
Title:
IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER
Timeline
Today
28.6.2016EP application
4.8.2021EP Publication
22.9.2021Translation submitted
15.10.2021Registration published
27.6.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
MULLIGAN, Christopher LeeAddress:
Princeton, New Jersey 08543, US
Name:
BARTLETT, Justin BlakeAddress:
Basking Ridge, New Jersey 07920, US
Name:
ROBBINS, Michael DarronAddress:
Princeton, New Jersey 08543, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562185968 PDate:
29.6.2015Country:
US
Number:
201562239965 PDate:
11.10.2015Country:
US
Number:
201562262574 PDate:
3.12.2015Country:
US
Classification
Categories:
A61P 35/02, A61K 39/395, A61K 31/454, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.5.2022
Expires: 27.6.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.5.2023
Expires: 27.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.5.2024
Expires: 27.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.6.2025
Expires: 27.6.2026
Payer: Árnason Faktor ehf.